Administration of Drugs to Treat COVID-19 in Uzbekistan
نویسندگان
1 Institute of Immunology and Human Genomics, Academy of Science of Republic of Uzbekistan, Tashkent, Uzbekistan
2 Institute of Immunology and Human Genomics, Academy of Science of Republic of Uzbekistan, Tashkent, Uzbekistan
3 Institute of Immunology and Human Genomics, Academy of Science of Republic of Uzbekistan, Tashkent, Uzbekistan
4 Institute of Immunology and Human Genomics, Academy of Science of Republic of Uzbekistan, Tashkent, Uzbekistan
5 Institute of Immunology and Human Genomics, Academy of Science of Republic of Uzbekistan, Tashkent, Uzbekistan
6 Institute of Immunology and Human Genomics, Academy of Science of Republic of Uzbekistan, Tashkent, Uzbekistan
7 Institute of Immunology and Human Genomics, Academy of Science of Republic of Uzbekistan, Tashkent, Uzbekistan
8 Institute of Immunology and Human Genomics, Academy of Science of Republic of Uzbekistan, Tashkent, Uzbekistan
9 Institute of Immunology and Human Genomics, Academy of Science of Republic of Uzbekistan, Tashkent, Uzbekistan
doi
10.30476/jhsss.2023.97266.1702چکیده
The COVID-19 pandemic has become a big challenge for the health systems of all countries. Since there were no reliable data on the efficacy of various drugs for COVID-19 in the early months of the pandemic, medical staff had to rely on constantly changing temporary recommendations and their experience in managing patients with COVID-19. In this regard, it is important to study the actions of medical personnel in a pandemic. In this study, we investigated the administration of drugs to treat COVID-19 in Uzbekistan. We demonstrated that physicians were swiftly adapting to new therapy recommendations; however, some drugs were not used appropriately, e.g., antibiotics and dexamethasone.
